NDUFA13 Antikörper (AA 1-29)
Kurzübersicht für NDUFA13 Antikörper (AA 1-29) (ABIN2585803)
Target
Alle NDUFA13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-29
-
Spezifität
- This NDUFA13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-29 amino acids from the N-terminal region of human NDUFA13.
-
Aufreinigung
- Affinity purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: ELISA (1:1000), WB (1:100 - 1:500)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for 1 year.
-
-
- NDUFA13 (NADH Dehydrogenase (Ubiquinone) 1 alpha Subcomplex, 13 (NDUFA13))
-
Andere Bezeichnung
- NDUFA13 / GRIM19
-
Hintergrund
-
Name/Gene ID: NDUFA13
Synonyms: NDUFA13, B16.6, CGI-39, CI-B16.6, Complex I-B16.6, GRIM-19, GRIM19, CDA016, Complex I B16.6 subunit -
Gen-ID
- 51079
-
Pathways
- Protein targeting to Nucleus, Negative Regulation of intrinsic apoptotic Signaling
Target
-